%0 Journal Article
%A Hong, David S
%A DuBois, Steven G
%A Kummar, Shivaani
%A Farago, Anna F
%A Albert, Catherine M
%A Rohrberg, Kristoffer S
%A van Tilburg, Cornelis M
%A Nagasubramanian, Ramamoorthy
%A Berlin, Jordan D
%A Federman, Noah
%A Mascarenhas, Leo
%A Geoerger, Birgit
%A Dowlati, Afshin
%A Pappo, Alberto S
%A Bielack, Stefan
%A Doz, François
%A McDermott, Ray
%A Patel, Jyoti D
%A Schilder, Russell J
%A Tahara, Makoto
%A Pfister, Stefan M
%A Witt, Olaf
%A Ladanyi, Marc
%A Rudzinski, Erin R
%A Nanda, Shivani
%A Childs, Barrett H
%A Laetsch, Theodore W
%A Hyman, David M
%A Drilon, Alexander
%T Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
%J The lancet  / Oncology Oncology
%V 21
%N 4
%@ 1470-2045
%C London
%I The Lancet Publ. Group
%M DKFZ-2020-00479
%P 531-540
%D 2020
%Z 2020 Apr;21(4):531-540
%X Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:32105622
%R 10.1016/S1470-2045(19)30856-3
%U https://inrepo02.dkfz.de/record/153861